Axoft’s Fleuron™ material is up to 10,000x softer than the polyimide used in existing brain implant devices and has been used in an in-human study at The Panama Clinic. Many iBCIs struggle to maintain ...

Axoft demonstrated the safety and functionality of its novel Fleuron™ material in the operating room, which was also featured in new research that outlines the technology’s clinical applications, and ...

BOSTON--(BUSINESS WIRE)--Axoft, a neurotechnology company, today launched and announced FDA Breakthrough Device designation for its brain-machine interface (BMI) to better treat neurological disorders ...

Axoft has received approval from the Ministry of Health of Panama and the Panama Clinic's Ethics Committee to conduct a first-in-human study of its novel soft materials that mimic the mechanical ...

Alex Knapp is a Forbes senior editor covering healthcare and science. Paul Le Floch’s company, Axoft, is developing brain implants made from soft, flexible materials that reduce injury and could treat ...

Axoft and MTS RED have signed a cooperation agreement. Axoft will supply in Russia a platform for managing secure development of MTS RED ASOC software, a system for improving cyber literacy of ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Rosatom will cooperate with Axoft in the field of integrated import substitution. Greenatom Simple Solutions has signed a distribution agreement with Axoft. This will allow Axoft partners and their ...

Axoft Announces Commercialization of Fleuron, Covered by an Exclusive License Agreement with Stanford University Axoft’s Fleuron™ material is up to 10,000x softer than the polyimide used in existing ...